Changing patterns of cardiovascular diseases and cancer mortality in Portugal, 1980–2010

BMC Public Health

Nuno Lunet³  Ana Azevedo³  Kathleen Bennett¹  Simon Capewell²  Bárbara Peleteiro³  Marta Pereira³ 

[1] Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, Dublin, Ireland;Department of Public Health and Policy, University of Liverpool, Liverpool, UK;Department of Clinical Epidemiology, Predictive Medicine and Public Health, University of Porto Medical School and Institute of Public Health of the University of Porto (ISPUP), Al. Prof. Hernâni Monteiro, Porto, 4200-319, Portugal

关键词: Portugal;    Trends;    Mortality;    Cardiovascular diseases;    Cancer;   

Others  :  1162682
DOI  :  10.1186/1471-2458-12-1126

 received in 2012-09-10, accepted in 2012-12-27,  发布年份 2012

【 摘 要 】

Background

Cardiovascular diseases and cancer are jointly responsible for more than half all deaths in Portugal. They also share some important risk factors and act as mutual competing risks. We aimed firstly to describe time trends in death rates and years of life lost due to cardiovascular diseases and cancer in the Portuguese population from 1980 to 2010; and secondly to quantify the contribution of the variation in population and age structure, and age-independent “risk” by cardiovascular or oncological causes to the change in the corresponding number of deaths.

Methods

We estimated the annual percent change in age-standardized mortality rates from cardiovascular diseases and cancer, in each sex. The specific contribution of demographic changes (due to changes in population size and in population age structure) and the variation in the age-independent “risk” of dying from the disease to the observed trends in the number of deaths was quantified using the tool RiskDiff. Years of life lost were computed using the Global Burden of Disease method.

Results

Among men, the mortality rate from all cardiovascular diseases was more than two-fold higher than cancer mortality in 1980. However, three decades later mortality from cancer surpassed cardiovascular diseases. After 2005, the years of life lost from cancer were also higher than from cardiovascular diseases. Among women, despite the decrease in death rates, cardiovascular diseases remained the leading cause of death in 2010 and their absolute burden was higher than that of cancers across the whole period, mainly due to more events in older women.

Conclusions

In Portugal, the 20th century witnessed a dramatic decrease in the cardiovascular disease mortality and YLL, and the transition towards cancer. In more recent years, the highest burdens of disease came from cancers in men and from cardiovascular diseases in women.

【 授权许可】

   
2012 Pereira et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]The global burden of disease 2004 update. Geneva: World Health Organization; 2008.
• [2]Levi F, Lucchini F, Negri E, La Vecchia C: Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world. Heart 2002, 88(2):119-124.
• [3]Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C: Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil 2009, 16(3):333-350.
• [4]La Vecchia C, Bosetti C, Lucchini F, Bertuccio P, Negri E, Boyle P, Levi F: Cancer mortality in Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol 2010, 21(6):1323-1360.
• [5]YLL by cause, in WHO Regions, estimates. 2004. http://www.who.int/healthinfo/global_burden_disease/estimates_regional/en/index.html webcite
• [6]Risco de Morrer em Portugal 2006. Lisboa: Direcção-Geral da Saúde; 2009.
• [7]Pereira M, Carreira H, Vales C, Rocha V, Azevedo A, Lunet N: Trends in hypertension prevalence (1990–2005) and mean blood pressure (1975–2005) in Portugal: a systematic review. Blood Press 2012, 27(4):220-226.
• [8]Alves L, Bastos J, Lunet N: Trends in lung cancer mortality in Portugal (1955–2005). Rev Port Pneumol 2009, 15(4):575-587.
• [9]Carreira H, Pereira M, Azevedo A, Lunet N: Trends in the prevalence of smoking in Portugal: a systematic review. BMC Public Health 2012, 12(1):958. [Epub ahead of print] BioMed Central Full Text
• [10]Óbitos (N.º) por Sexo e Causa de morte; Anual. http://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_main webcite
• [11]Estimativas Anuais da População Residente. http://www.ine.pt/xportal/xmain?xpid=INE&xpgid=ine_main webcite
• [12]Waterhouse JAH, Muir CS, Correa P, Powell J: Cancer incidence in five continents. Lyon: IARC; 1976.
• [13]Software: Jointpoint regression program. Version 3.4. http://surveillance.cancer.gov/joinpoint/ webcite
• [14]Kim H-J, Fay MP, Feuer EJ, Midthune DN: Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 2000, 19(3):335-351.
• [15]Mathers C, Vos T, Lopez A, Salomon J, Ezzati M: National Burden of Disease Studies: A Practical Guide. In Global Program on Evidence for Health Policy. 20 E edition. Geneva: World Health Organization; 2001.
• [16]RiskDiff: web-based application. http://rht.iconcologia.net/riskdiff.htm webcite
• [17]Forthofer R, Lee E, Hernandez M: Biostatistics: a guide to design, analysis, and discovery. Oxford: Elsevier; 2007.
• [18]Allender S, Scarborough P, Peto V, Rayner M, Leal J, Luengo-Fernandez R, Gray A: European Cardiovascular Disease Statistics, 2008 edition. University of Oxford: Department of Public Health; 2008.
• [19]Giovannetti L, Gorini G, Martini A, Chellini E, Fornai MG, Sorso B, Seniori-Costantini A: Is cancer overtaking cardiovascular diseases as the killer number one in men in Tuscany? Tumori 2011, 97:14-18.
• [20]Machado V, Lima G, Teixeira C, Felício M, Northern Region Health Administration Public Institute: Global Burden of Disease in the Northern Region of Portugal. 2011.
• [21]Ribeiro AI, Lopes C, Barros H, de Pina MF: After a quarter of century, reduction in Coronary Heart Disease Mortality bypassed young adult males in Portugal. Int J Cardiol 2011, 152(2):279-281.
• [22]Risco de Morrer em Portugal 1990. Lisboa: Direcção-Geral dos Cuidados de Saúde Primários; 1992.
• [23]Sarti C, Rastenyte D, Cepaitis Z, Tuomilehto J: International trends in mortality from stroke, 1968 to 1994. Stroke 2000, 31(7):1588-1601.
• [24]Fonseca T, Clara JG: Stroke units. The first-year results of Pulido Valente Hospital Stroke Unit. Rev Port Cardiol 2004, 23(10):1227-1241.
• [25]Palmieri L, Bennett K, Giampaoli S, Capewell S: Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 2010, 100(4):684-692.
• [26]Ford ES, Ajani UA, Croft JB, Critchley JA, Labarthe DR, Kottke TE, Giles WH, Capewell S: Explaining the decrease in U.S. deaths from coronary disease, 1980–2000. N Engl J Med 2007, 356(23):2388-2398.
• [27]Unal B, Critchley JA, Capewell S: Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004, 109(9):1101-1107.
• [28]Laatikainen T, Critchley J, Vartiainen E, Salomaa V, Ketonen M, Capewell S: Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005, 162(8):764-773.
• [29]Carreira H, Pereira M, Alves L, Lunet N, Azevedo A: Dyslipidaemia, and mean blood cholesterol and triglycerides levels in the Portuguese population: a systematic review. Arq Med 2012, 26(3):112-123.
• [30]Santos JF, Aguiar C, Gavina C, Azevedo P, Morais J: Portuguese Registry of Acute Coronary Syndromes: seven years of activity. Rev Port Cardiol 2009, 28(12):1465-1500.
• [31]Gilboa SM, Salemi JL, Nembhard WN, Fixler DE, Correa A: Mortality resulting from congenital heart disease among children and adults in the United States, 1999 to 2006. Circulation 2010, 122(22):2254-2263.
• [32]Bosetti C, Malvezzi M, Rosso T, Bertuccio P, Gallus S, Chatenoud L, Levi F, Negri E, La Vecchia C: Lung cancer mortality in European women: Trends and predictions. Lung Cancer 2012, 78(3):171-178.
• [33]Karim-Kos HE, de Vries E, Soerjomataram I, Lemmens V, Siesling S, Coebergh JW: Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s. Eur J Cancer 2008, 44(10):1345-1389.
• [34]Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, et al.: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011, 377(9765):557-567.
• [35]Chen Q, Marques-Vidal P: Trends in food availability in Portugal in 1966–2003: comparison with other Mediterranean countries. Eur J Nutr 2007, 46(7):418-427.
• [36]Strong K, Guthold R, Yang J, Lee D, Petit P, Fitzpatrick C: Tobacco use in the European region. Eur J Cancer Prev 2008, 17(2):162-168.
• [37]Bastos J, Peleteiro B, Gouveia J, Coleman MP, Lunet N: The state of the art of cancer control in 30 European countries in 2008. Int J Cancer 2010, 126(11):2700-2715.
• [38]Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD: Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 2005, 83(3):171-177.
• [39]Correia M, Silva MR, Matos I, Magalhaes R, Lopes JC, Ferro JM, Silva MC: Prospective community-based study of stroke in Northern Portugal: incidence and case fatality in rural and urban populations. Stroke 2004, 35(9):2048-2053.